Stage IIIC Intraocular Melanoma
3 clinical trials · Condition
◉ Watch Stage IIIC Intraocular Melanoma
| Record | Firm | Date |
|---|---|---|
| Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma (NCT02068586) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2014-11-19 |
| Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery (NCT01533948) | Roswell Park Cancer Institute | 2012-01-01 |
| Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma (NCT00085189) | University of Southern California | 2004-05-01 |
Track Stage IIIC Intraocular Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.